Cardio <3 Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

Non-genetic risk factors to cardiomyopathy

A

hypertension, DM, thyroid disease, chemo exposure, obesity, long term alochol misuse, illicit drug use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is hypertrophic cardiomyopathy

A

left ventricular outflow tract obstruction and mitral valve regurgitation, diastolic dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Syndromic causes of HCM

A

Fabry disease
Pompe disease
RASopathies (i.e. Noonan)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Non-syndromic, genetic
causes of HCM

A

most common genes: MYBPC3 (50%)
MYH7 (33%)
MOI: AD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Fabry disease

A

Gene: GLA
MOI: X-linked
phenotype: periodic pain crisis, angiokeratomas, hyperhidrosis, ocular abnormalities, kidney disease
Heart: HCM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Pompe disease

A

Gene: GAA
MOI: AR
Phenotype: poor feeding, macroglossia, motor delay / muscle weakness, respiratory difficulties
Heart: HCM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Noonan

A

RASopathies
Gene: most common PTPN11
MOI: AD
Phenotype: characteristic facial features, short stature, developmental delay, webbed neck
Heart: HCM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Cardiac amyloidosis (amyloid cardiomyopathy)

A

Disease caused by the buildup of abnormal proteins in the heart. *Symptoms include fatigue, weakness, shortness of breath, dizziness, swelling of abdomen and legs.
Gene: TTR
MOI: AD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Dilated Cardiomyopathy is characterized by

A

Left ventricular enlargement
Systolic dysfunction (EF < 50%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Syndromic associations of DCM

A

Duchene and Becker muscular atrophy
Carvajal syndrome
Barth syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Non-syndromic, genetic causes of DCM

A

MOI: typically AD
Genes:
TTN ~15-20% Truncating variants
LMNA ~6%
MYH7 ~4%
Others… FLNC, BAG3, TNNT2, RBM20, SCN5I, DES, PLN, … + more

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Duchene and Becker muscular atrophy

A

heart: DCM
Gene: DMD
MOI: X-linked
Features:
Muscle weakness
Elevated CK
Loss of ambulation in males

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Carvajal syndrome

A

heart: DCM
Gene: DSP
MOI: AR
Features:
Wooly hair
Palmoplantar keratoderma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Barth syndrome

A

Heart: DCM
Gene: TAFAZZIN
MOI: X-linked
Features:
neuropathy
Muscle weakness
Growth delay
infantile/early childhood onset

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Arrythmogenic cardiomyopathy

A

Prevalence: ~1 in 1000
Accounts for ~11% of young adult sudden cardiac death cases
Average age of dx: 31 (but variable)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Genetic causes of arrythmogenic cardiomyopathy

A

MOI: typically AD
More common causes
Associated with desmosomal proteins
PKP2 , DSP, DSC2, DSG2, JUP, TMEM43
Less common: CTNNA3, DES, LMNA, PLN, RYR2, TGFB3, TTN

17
Q

characteristics of restrictive cardiomyopathy

A

Myocardial stiffness w/ normal/mildly increased wall thickness
Generally diastolic dysfunction, but normal/mildly reduced EF

18
Q

Causes of restrictive cardiomyopathy

A

Infiltrative disorders (amyloidosis, hemochromatosis, others)
Inflammatory disorders (sarcoidosis, scleroderma)
Treatment-related cardiotoxicity (radiation therapy)
Genes overlapping with those related to HCM and/or DCM I.e. TTR,
Still unexplained

19
Q

Characteristics of left-ventricular non-compaction

A

Abnormal muscle leads to risk for arrhythmia, thromboembolism, LV dysfunction
Prevalence: ~2-10%

20
Q

Genetic testing for left-ventricular non-compaction

A

Genetic testing should be guided by cardiomyopathy or other cardiovascular phenotype
If asymptomatic and otherwise normal heart structure/function then genetic testing not recommended, no specific family screening recommendations

21
Q

Screening tools for cardio

A

ECG/EKG
Holter (wearable ECG)
Exercise treadmill test
Echo

22
Q

Sudden cardiac death accounts for _% of mortality in the general population

A

20%

23
Q

Phenotype of Brugada syndrome

A

Ventricular arrhythmias & sudden death
Symptoms seen in adulthood; sudden death mean age is 40y if untreated. Peds onset is rare
More prevalent in males

24
Q

Brugada syndrome gene

A

SCN5A (30%)

25
Q

Phenotype for Catecholamiergic polymorphic ventricular tachycardia

A

exercise and high emotions stress = tachycardia and syncope
Syncope episodes start around 7y - 12y
Incorrect dx of epilepsy due to seizure like activity during syncope

26
Q

Treatment for Catecholamiergic polymorphic ventricular tachycardia

A

beta blockers

27
Q

genes for Catecholamiergic polymorphic ventricular tachycardia

A

GENES:
AD: RYR2, CALM
AR: CASQ2, TRDN

28
Q

Phenotype for Long QT syndrome

A

Phenotype: syncope + arrhythmias with prolonged QT interval = LQTS phenotype
Arrhythmia episode leads to faithing (looks like seizure)… leading cause of SCD if left untreated under the age of 35

29
Q

Syndromes associated with Long-QT

A

Jervell-Lange-Neilson : profound sensorineural hearing loss
Timothy Type B: Hand/foot deformities and neurodevelopmental
Andersen-Tawil (Type 7): Muscle weakness, dysmorphism

30
Q

Genes associated to Long QT

A

KCNQ1, KCNH2, SCN5A KCNE1, KCNE2

31
Q

phenotype for early onset atrial fibrillation

A

Irregular heartbeat- can be too fast, too slow, or mixed
Increases risk for stroke, heart failure

32
Q

Genes for early onset atrial fibrillation

A

KCNQ1
SCN5A
LAMIN A/C

33
Q

phenotype for familial hypercholesterolemia

A

very high total cholesterol and LDL, xanthomas, corneal arc
Incidence: 1 in 250
90% are undiagnosed

34
Q

genes associated to familial hypercholesterolemia

A

LDLR, APOE, PCSK9

35
Q

Treatment for familial hypercholesterolemia

A

statins as early as 8-10y